Recruiting
Phase 2

Daratumumab to Treat Active Lupus Nephritis

Sponsor:

Mayo Clinic

Code:

NCT04868838

Conditions

Lupus Nephritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Daratumumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information